Skip to main content
logo
NRx Pharmaceuticals, Inc. (NRXP)
NASDAQ: NRXP · Real-Time Price · USD
4.140
+0.090 (2.22%)
At close: Jun 5, 2026, 4:00 PM EDT
4.081
-0.059 (-1.43%)
After-hours: Jun 5, 2026, 7:58 PM EDT

NRx Pharmaceuticals Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-24.54-28.62-25.13-30.15-39.75-93.06
Depreciation & Amortization
0.290.140.010.0100
Stock-Based Compensation
0.370.230.490.393.637.79
Other Adjustments
12.2512.698.712.94-4.3352.47
Change in Receivables
-0.010.05---0.83
Changes in Accounts Payable
0.060.11-5.222.66-1.61-0.02
Changes in Accrued Expenses
-0.140.510.01-0.532.94-0.9
Changes in Other Operating Activities
0.520.750.53.04-0.63-4.81
Operating Cash Flow
-14.93-14.11-10.64-21.66-39.76-37.7
Capital Expenditures
----0-0.01-0.01
Proceeds from Sale of Investments
-0.21-0.43----
Payments for Business Acquisitions
0.18-2.38----
Investing Cash Flow
-0.46-2.81--0-0.01-0.01
Long-Term Debt Issued
05.237.080.9410.02-
Long-Term Debt Repaid
-0.23-0.55-8.58-4.04-0.52-1.28
Net Long-Term Debt Issued (Repaid)
-0.234.68-1.5-3.099.5-1.28
Issuance of Common Stock
19.1218.959.888.1222.7164.73
Net Common Stock Issued (Repurchased)
19.1218.959.888.1222.7164.73
Issuance of Preferred Stock
---1.17--
Net Preferred Stock Issued (Repurchased)
---1.17--
Other Financing Activities
--0.35-0.9---
Financing Cash Flow
19.1223.287.496.232.2163.46
Net Cash Flow
1.176.35-3.15-15.46-7.5525.75
Free Cash Flow
-14.93-14.11-10.64-21.66-39.77-37.71
FCF Margin
-650.98%-1152.00%----
Free Cash Flow Per Share
-0.59-0.66-1.00-2.86-6.05-8.04
Levered Free Cash Flow
-24.04-22.44-21.33-28.09-29.56-355.9
Unlevered Free Cash Flow
-16.39-14.72-13.21-22.67-43.64-121.53
SEC Filings: 10-K · 10-Q